Activin type II receptor signaling in cardiac aging and heart failure

ATPase (SERCA2a), a critical determinant of cardiomyocyte function. Together, our findings suggest that increased activin/ActRII signaling links aging and HF pathobiology and that targeted inhibition of this catabolic pathway holds promise as a therapeutic strategy for multiple forms of HF.

Activin type II receptor signaling in cardiac aging and heart failure | Litlas